Evaluation of the combined therapeutic effect of methylprednisolone and cerebrolysin in traumatic medullar lesion

Evaluation of the combined therapeutic effect of methylprednisolone and cerebrolysin in traumatic medullar lesion

Objectives: The pharmacological effects of Methylprednisolone and Cerebrolysin have been extensively debated, but from our knowledge there are no studies to evaluate the association of these two drugs in spinal cord injury (SCI). Methods: Twenty-four Wistar rats underwent traumatic spinal cord injur...

Full description

Bibliographic Details
Main Authors:	Adriana Baritchii, Lăcrămioara Perju-Dumbravă, Anca Buzoianu, Aurel Oşlobanu, Horaţiu Ioani, Dragoş Tusnea, S. Cadar, E. Levei, Ioan Groza, Aurel Muşte, Cristiana Ciortea, Ioan Ştefan Florian
Format:	Article
Language:	English
Published:	London Academic Publishing 2011-12-01
Series:	Romanian Neurosurgery
Subjects:	Cerebrolysin Methyl-prednisolone motor recovery spinal cord injury
Online Access:	https://www.journals.lapub.co.uk/index.php/roneurosurgery/article/view/607

Similar Items

Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of the CARS Study
by: Stefan Strilciuc, et al.
Published: (2023-05-01)

Cerebrolysin in Patients with TBI: Systematic Review and Meta-Analysis
by: Konrad Jarosz, et al.
Published: (2023-03-01)

Cerebrolysin Use in Patients with Liver Damage—A Translational Study
by: Shandiz Morega, et al.
Published: (2022-11-01)

Cerebrolysin as a New Treatment Option for Post-Stroke Spasticity: Patient and Physician Perspectives
by: Nataliia Chemer, et al.
Published: (2019-02-01)

Cerebrolysin in Patients with Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
by: Klaudyna Kojder, et al.
Published: (2023-10-01)

Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation
by: Gustavo Villarreal-Reyna, et al.
Published: (2022-11-01)

Effect of cerebrolysin on motor function restoration during medical rehabilitation
by: M. A. Kustova, et al.
Published: (2016-07-01)

Effects of Cerebrolysin on Hippocampal Neuronal Death After Pilocarpine-Induced Seizure
by: Dong Hyeon Kang, et al.
Published: (2020-10-01)

Role and Impact of Cerebrolysin for Ischemic Stroke Care
by: Dafin F. Mureșanu, et al.
Published: (2022-02-01)

The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis
by: Ioana Anamaria Mureșanu, et al.
Published: (2022-05-01)

Safety of Cerebrolysin for Neurorecovery after Acute Ischemic Stroke: A Systematic Review and Meta-Analysis of Twelve Randomized-Controlled Trials
by: Stefan Strilciuc, et al.
Published: (2021-12-01)

Effect of cerebrolysin on dopaminergic neurodegeneration of rat with oxidative stress induced by 3-nitropropionic acid
by: Calderón Guzmán David, et al.
Published: (2016-09-01)

Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study
by: Dina R. Khasanova, et al.
Published: (2023-03-01)

Protective effects of cerebrolysin in a rat model of optic nerve crush
by: Tzu-Lun Huang, et al.
Published: (2014-07-01)

Cerebrolysin recovers diaphragmatic function and reduces injury-associated astrogliosis following a cervical spinal cord hemi-section injury in rats
by: Samah Fouad, et al.
Published: (2023-08-01)

Effects of Cerebrolysin® in Patients With Minimally Conscious State After Stroke: An Observational Retrospective Clinical Study
by: Jun Yup Kim, et al.
Published: (2019-08-01)

Additive effect of cerebrolysin and amantadine on disorders of consciousness secondary to acquired brain injury: A retrospective case-control study
by: Seunghwan Lee, et al.
Published: (2020-02-01)

Heterogeneous treatment effects of Cerebrolysin as an early add-on to reperfusion therapy: post hoc analysis of the CEREHETIS trial
by: Mikhail N. Kalinin, et al.
Published: (2024-01-01)

Cerebrolysin Combined with Rehabilitation Enhances Motor Recovery and Prevents Neural Network Degeneration in Ischemic Stroke Patients with Severe Motor Deficits
by: Won Hyuk Chang, et al.
Published: (2021-06-01)

Efficacy and safety of CDP-choline, cerebrolysin, MLC601, and edaravone in recovery of patients with acute ischemic strokes: a meta-analysis
by: Shafiq Dexter B. Abou Zaki, et al.
Published: (2023-10-01)

Cerebrolysin for functional recovery in patients with acute ischemic stroke: a meta-analysis of randomized controlled trials
by: Wang ZF, et al.
Published: (2017-04-01)

Comparative neuroprotective effects of Cerebrolysin, dexamethasone, and ascorbic acid on sciatic nerve injury model: Behavioral and histopathological study
by: Heba M. Elhessy, et al.
Published: (2023-02-01)

Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients With Acute Ischemic Stroke Due to Large Vessel Occlusion: Study Protocol for a Prospective, Open Label, Single-Center Study With 12 Months of Follow-Up
by: Jacek Staszewski, et al.
Published: (2022-07-01)

Extended Poststroke Rehabilitation Combined with Cerebrolysin Promotes Upper Limb Motor Recovery in Early Subacute Phase of Rehabilitation: A Randomized Clinical Study
by: Sindi Z. Mitrović, et al.
Published: (2023-02-01)

Cerebrolysin and repetitive transcranial magnetic stimulation (rTMS) in patients with traumatic brain injury: a three-arm randomized trial
by: Olivia Verisezan Rosu, et al.
Published: (2023-06-01)

Cerebrolysin: spectrum of activity and research data
by: N. D. Bukreeva, et al.
Published: (2018-07-01)

The Effects of Neuromonitoring and Cerebrolysin Administration on Outcomes in Patients with Traumatic Brain Injury—An Interventional Pilot Study
by: Konrad Jarosz, et al.
Published: (2024-01-01)

Effects of cerebrolysin on functional outcome of patients with traumatic brain injury: a systematic review and meta-analysis
by: Ghaffarpasand F, et al.
Published: (2018-12-01)

Cerebrolysin: spectrum of activity and research data. Part 2
by: N. D. Bukreeva, et al.
Published: (2018-07-01)

Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves′ orbitopathy: A randomized controlled trial
by: Ajitesh Roy, et al.
Published: (2015-01-01)

Cerebrolysin Ameliorates Focal Cerebral Ischemia Injury Through Neuroinflammatory Inhibition via CREB/PGC-1α Pathway
by: Xin Guan, et al.
Published: (2019-10-01)

Effect of methylprednisolone in medullar injury in rats: a functional and histological analysis
by: Tebet Marcos Antônio, et al.
Published: (2003-01-01)

The influence of neurotrophic factors treatment on stroke volume
by: Adina Dora Stan, et al.
Published: (2013-09-01)

Safety and Effectiveness of Oral Methylprednisolone Therapy in Comparison With Intramuscular Adrenocorticotropic Hormone and Oral Prednisolone in Children With Infantile Spasms
by: Hong-Min Zhu, et al.
Published: (2021-12-01)

A Pilot Randomized Trial to Compare Polyuria and Polydipsia during a Short Course of Prednisolone or Methylprednisolone in Dogs with Atopic Dermatitis
by: Viktorija Lokianskiene, et al.
Published: (2022-09-01)

Neuroprotective therapy in acute ischemic stroke
by: A. A. Kulesh
Published: (2021-08-01)

Patient and Physician Perspectives in a Case of Severe Traumatic Brain Injury
by: Rhoderick M. Casis
Published: (2018-11-01)

Treatment of ITP, prednisolone versus IVIG: a 12 month study in Children's Medical Center
by: Ramyar A, et al.
Published: (2008-06-01)

The Effect of Cerebrolysin in an Animal Model of Forebrain Ischemic-Reperfusion Injury: New Insights into the Activation of the Keap1/Nrf2/Antioxidant Signaling Pathway
by: Basma H. Marghani, et al.
Published: (2023-07-01)

Geroprotective properties of neuroprotective and neurotrophic peptides
by: O. A. Gromova, et al.
Published: (2020-02-01)